{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T00:06:58Z","timestamp":1758931618555,"version":"3.44.0"},"reference-count":42,"publisher":"BMJ","issue":"2","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Inj Prev"],"accepted":{"date-parts":[[2021,5,27]]},"published-print":{"date-parts":[[2022,4]]},"abstract":"<jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Prescription drug use has soared in the USA within the last two decades. Prescription drugs can impair motor skills essential for the safe operation of a motor vehicle, and therefore can affect traffic safety. As one of the epicentres of the opioid epidemic, Florida has been struck by high opioid misuse and overdose rates, and has concurrently suffered major threats to traffic disruptions safety caused by driving under the influence of drugs. To prevent prescription opioid misuse in Florida, Prescription Drug Monitoring Programs (PDMPs) were implemented in September 2011.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>To examine the impact of Florida\u2019s implementation of a mandatory PDMP on drug-related MVCs occurring on public roads.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We employed a difference-in-differences approach to estimate the difference in prescription drug-related fatal crashes in Florida associated with its 2011 PDMP implementation relative to those in Georgia, which did not use PDMPs during the same period (2009\u20132013). The analyses were conducted in 2020.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>In Florida, there was a significant decline in drug-related vehicle crashes during the 22 months post-PDMP. PDMP implementation was associated with approximately two (\u22122.21; 95% CI \u22124.04 to \u20130.37; p&lt;0.05) fewer prescribed opioid-related fatal crashes every month, indicating 25% reduction in the number of monthly crashes. We conducted sensitivity analyses to investigate the impact of PDMP implementation on central nervous system depressants and stimulants as well as cocaine and marijuana-related fatal crashes but found no robust significant reductions.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>The implementation of PDMPs in Florida provided important benefits for traffic safety, reducing the rates of prescription opioid-related vehicle crashes.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/injuryprev-2020-044113","type":"journal-article","created":{"date-parts":[[2021,6,23]],"date-time":"2021-06-23T13:38:22Z","timestamp":1624455502000},"page":"105-109","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":2,"title":["Impact of Florida\u2019s prescription drug monitoring program on drug- related fatal vehicle crashes: a difference-in-differences approach"],"prefix":"10.1136","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0342-4293","authenticated-orcid":false,"given":"Moosa","family":"Tatar","sequence":"first","affiliation":[{"name":"Matheson Center for Health Care Studies, University of Utah Health, Salt Lake City, Utah, USA"},{"name":"Department of Health Services Research and Administration, University of Nebraska Medical Center, Omaha, Nebraska, USA"},{"name":"Department of Population Health Sciences, University of Utah, Salt Lake City, Utah, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6769-2732","authenticated-orcid":false,"given":"Mohammad S.","family":"Jalali","sequence":"additional","affiliation":[{"name":"Harvard Medical School, MGH Institute for Technology Assessment, Boston, Massachusetts, USA"},{"name":"Sloan School of Management, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyo Jung","family":"Tak","sequence":"additional","affiliation":[{"name":"Department of Health Services Research and Administration, University of Nebraska Medical Center, Omaha, Nebraska, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-Wu","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Health Sciences, School of Health Professions, University of Missouri, Columbia, Missouri, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ozgur M.","family":"Araz","sequence":"additional","affiliation":[{"name":"College of Business, University of Nebraska-Lincoln, Lincoln, Nebraska, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando A.","family":"Wilson","sequence":"additional","affiliation":[{"name":"Matheson Center for Health Care Studies, University of Utah Health, Salt Lake City, Utah, USA"},{"name":"Department of Population Health Sciences, University of Utah, Salt Lake City, Utah, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2021,6,23]]},"reference":[{"key":"2025092603521837000_28.2.105.1","doi-asserted-by":"crossref","unstructured":"Gu Q , Dillon CF , Burt VL . Prescription drug use continues to increase: U.S. prescription drug data for 2007-2008. NCHS Data Brief 2010:1\u20138.","DOI":"10.1037\/e665492010-001"},{"key":"2025092603521837000_28.2.105.2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2015.13766"},{"key":"2025092603521837000_28.2.105.3","doi-asserted-by":"publisher","DOI":"10.2146\/ajhp130767"},{"key":"2025092603521837000_28.2.105.4","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1080\/15389580802593202","article-title":"Repeat DUI offenders who have had a drug diagnosis: are they more prone to traffic crashes and violations?","volume":"10","author":"C'de Baca","year":"2009","journal-title":"Traffic Inj Prev"},{"key":"2025092603521837000_28.2.105.5","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.1464"},{"key":"2025092603521837000_28.2.105.6","doi-asserted-by":"publisher","DOI":"10.1016\/j.aap.2013.09.001"},{"key":"2025092603521837000_28.2.105.7","doi-asserted-by":"publisher","DOI":"10.1177\/003335491412900409"},{"key":"2025092603521837000_28.2.105.8","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.2105\/AJPH.2017.303902","article-title":"Trends in prescription opioids detected in fatally injured drivers in 6 US states: 1995-2015","volume":"107","author":"Chihuri","year":"2017","journal-title":"Am J Public Health"},{"key":"2025092603521837000_28.2.105.9","first-page":"1","article-title":"Unintentional injury death rates in rural and urban areas: United States, 1999-2017","author":"Olaisen","year":"2019","journal-title":"NCHS Data Brief"},{"key":"2025092603521837000_28.2.105.10","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2012.300960"},{"key":"2025092603521837000_28.2.105.11","unstructured":"Florida Board of Medicine . Prescription drug monitoring program, 2014. Available: http:\/\/flboardofmedicine.gov\/latest-news\/prescription-drug-monitoring-program-2\/ [Accessed 6 Apr 2020]."},{"key":"2025092603521837000_28.2.105.12","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2012.03993.x"},{"key":"2025092603521837000_28.2.105.13","unstructured":"National Highway Traffic Safety Administration . Fatality analysis reporting system (FARS), 2019. Available: https:\/\/www-fars.nhtsa.dot.gov\/Main\/index.aspx [Accessed 24 Oct 2019]."},{"key":"2025092603521837000_28.2.105.14","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1111\/1556-4029.12999","article-title":"Manners of death in drug-related fatalities in Florida","volume":"61","author":"Lee","year":"2016","journal-title":"J Forensic Sci"},{"key":"2025092603521837000_28.2.105.15","unstructured":"Prescription Drug Monitoring Program Training and Technical Assistance Center . PDMP Legislation & Operational Dates, 2020. Available: https:\/\/www.pdmpassist.org\/pdf\/Legislative_Operational_Dates_20200207.pdf [Accessed 14 Dec 2019]."},{"key":"2025092603521837000_28.2.105.16","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1097\/j.pain.0000000000001078","article-title":"High-risk prescribing and opioid overdose: prospects for prescription drug monitoring program-based proactive alerts","volume":"159","author":"Geissert","year":"2018","journal-title":"Pain"},{"key":"2025092603521837000_28.2.105.17","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-019-4537-8"},{"key":"2025092603521837000_28.2.105.18","unstructured":"Finklea KM , Bagalman E , Sacco LN . Prescription drug monitoring programs. Washington, DC: Congressional Research Service, 2014."},{"key":"2025092603521837000_28.2.105.19","unstructured":"PDMP TTAC . State PDMP profiles and contacts. PDMP TTAC, 2020. Available: https:\/\/www.pdmpassist.org\/State [Accessed 1 May 2021]."},{"key":"2025092603521837000_28.2.105.20","unstructured":"Florida Department of Health . 2011-2012 prescription drug monitoring program annual report, 2012. Available: http:\/\/www.floridahealth.gov\/statistics-and-data\/e-forcse\/news-reports\/_documents\/2011-2012pdmp-annual-report.pdf [Accessed 25 Feb 2020]."},{"key":"2025092603521837000_28.2.105.21","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1001\/jamainternmed.2015.3931","article-title":"Effect of Florida's prescription drug monitoring program and pill Mill laws on opioid prescribing and use","volume":"175","author":"Rutkow","year":"2015","journal-title":"JAMA Intern Med"},{"key":"2025092603521837000_28.2.105.22","doi-asserted-by":"publisher","DOI":"10.1002\/pds.3553"},{"key":"2025092603521837000_28.2.105.23","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2015.02.010"},{"key":"2025092603521837000_28.2.105.24","unstructured":"United States Census Bureau . State profile, 2020. Available: https:\/\/data.census.gov\/cedsci\/profile?q=United%20States&g=0100000US&tid=ACSDP1Y2018.DP05 [Accessed 17 Jul 2020]."},{"key":"2025092603521837000_28.2.105.25","unstructured":"Berning A , Smither DD . Understanding the limitations of drug test information, reporting, and testing practices in fatal crashes: traffic safety facts: research note. United States. Department of transportation. National Highway Traffic Safety, 2014."},{"key":"2025092603521837000_28.2.105.26","unstructured":"Administration NHTS . Drug involvement of fatally injured drivers. US Department of Transportation Report No DOT HS, 2010."},{"key":"2025092603521837000_28.2.105.27","unstructured":"US Department of Transportation . Monthly gasoline\/gasohol reported by states, 2020. Available: https:\/\/www.fhwa.dot.gov\/policyinformation\/motorfuelhwy_trustfund.cfm [Accessed 30 Mar 2020]."},{"key":"2025092603521837000_28.2.105.28","unstructured":"Bureau USC . National population Totals: 2010-2019, 2020. Available: https:\/\/www.census.gov\/data\/tables\/time-series\/demo\/popest\/2010s-national-total.html [Accessed 4 Aug 2020]."},{"key":"2025092603521837000_28.2.105.29","unstructured":"United States Census Bureau . State Intercensal tables: 2000-2010, 2012. Available: https:\/\/www.census.gov\/data\/tables\/time-series\/demo\/popest\/intercensal-2000-2010-state.html [Accessed 4 Aug 2020]."},{"key":"2025092603521837000_28.2.105.30","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2014.16153"},{"key":"2025092603521837000_28.2.105.31","doi-asserted-by":"publisher","DOI":"10.1111\/1475-6773.12270"},{"key":"2025092603521837000_28.2.105.32","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.drugalcdep.2017.05.023","article-title":"Impact of New York prescription drug monitoring program, I-STOP, on statewide overdose morbidity","volume":"178","author":"Brown","year":"2017","journal-title":"Drug Alcohol Depend"},{"key":"2025092603521837000_28.2.105.33","first-page":"569","article-title":"Decline in drug overdose deaths after state policy changes - Florida, 2010-2012","volume":"63","author":"Johnson","year":"2014","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2025092603521837000_28.2.105.34","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.addbeh.2017.01.011","article-title":"Prescription drug monitoring programs, nonmedical use of prescription drugs, and heroin use: evidence from the National survey of drug use and health","volume":"69","author":"Ali","year":"2017","journal-title":"Addict Behav"},{"key":"2025092603521837000_28.2.105.35","doi-asserted-by":"crossref","unstructured":"Mallatt J . Unintended consequences of prescription monitoring: Policy-induced substitution to illicit drugs, 2019.","DOI":"10.2139\/ssrn.3418615"},{"key":"2025092603521837000_28.2.105.36","unstructured":"Administration NHTS . 2010 motor vehicle crashes: overview. Washington, DC: US Department of Transportation, 2012."},{"key":"2025092603521837000_28.2.105.37","unstructured":"Administration NHTS . 2014 motor vehicle crashes: overview. Washington, DC: US Department of Transportation, 2016."},{"key":"2025092603521837000_28.2.105.38","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2015.302953"},{"key":"2025092603521837000_28.2.105.39","unstructured":"Blincoe L , Miller TR , Zaloshnja E . The economic and societal impact of motor vehicle crashes, 2010 (Revised), 2015."},{"key":"2025092603521837000_28.2.105.40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12961-020-00596-8","article-title":"The opioid crisis: a contextual, social-ecological framework","volume":"18","author":"Jalali","year":"2020","journal-title":"Health Res Policy Sys"},{"key":"2025092603521837000_28.2.105.41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12961-020-00598-6","article-title":"The opioid crisis: need for systems science research","volume":"18","author":"Jalali","year":"2020","journal-title":"Health Res Policy Sys"},{"key":"2025092603521837000_28.2.105.42","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.jval.2020.07.013","article-title":"Economic evaluation in opioid modeling: systematic review","volume":"24","author":"Beaulieu","year":"2021","journal-title":"Value Health"}],"container-title":["Injury Prevention"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/injuryprev-2020-044113","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T10:52:27Z","timestamp":1758883947000},"score":1,"resource":{"primary":{"URL":"https:\/\/injuryprevention.bmj.com\/lookup\/doi\/10.1136\/injuryprev-2020-044113"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,23]]},"references-count":42,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2022,3,21]]},"published-print":{"date-parts":[[2022,4]]}},"alternative-id":["10.1136\/injuryprev-2020-044113"],"URL":"https:\/\/doi.org\/10.1136\/injuryprev-2020-044113","relation":{},"ISSN":["1353-8047","1475-5785"],"issn-type":[{"type":"print","value":"1353-8047"},{"type":"electronic","value":"1475-5785"}],"subject":[],"published":{"date-parts":[[2021,6,23]]}}}